Pharmaceutics (Oct 2020)

Current Advances in the Development of Diagnostic Tests Based on Aptamers in Parasitology: A Systematic Review

  • Juan David Ospina-Villa,
  • Alondra Cisneros-Sarabia,
  • Miryan Margot Sánchez-Jiménez,
  • Laurence A. Marchat

DOI
https://doi.org/10.3390/pharmaceutics12111046
Journal volume & issue
Vol. 12, no. 11
p. 1046

Abstract

Read online

Aptamers are single-stranded DNA or RNA sequences of 20–80 nucleotides that interact with different targets such as: proteins, ions, viruses, or toxins, through non-covalent interactions and their unique three-dimensional conformation. They are obtained in vitro by the systematic evolution of ligands by exponential enrichment (SELEX). Because of their ability of target recognition with high specificity and affinity, aptamers are usually compared to antibodies. However, they present many advantages that make them promising molecules for the development of new methods for the diagnosis and treatment of human diseases. In medical parasitology, aptamers also represent an attractive alternative for the implementation of new parasite detection methods, easy to apply in endemic regions. The aim of this study was to describe the current advances in the development of diagnostic tests based on aptamers in parasitology. For this, articles were selected following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, with specific inclusion and exclusion criteria. The 26 resulting articles deal with the use of aptamers for the detection of six important protozoa that affect human health. This systematic review clearly demonstrates the specificity, sensitivity and selectivity of aptamers and aptasensors, that certainly will soon become standard methods in medical parasitology.

Keywords